Expert Opinion on Drug Metabolism & Toxicology
SCI一区
EI同步收录
月刊
高认可度
更新时间: 浏览量:
期刊基础介绍
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The Editors welcome:
Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.
Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.
The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
The Editors welcome:
Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.
Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.
The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
期刊核心参数
通讯方式
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
涉及的研究方向
医学-生化与分子生物学
出版国家或地区
ENGLAND
出版语言
English
年文章数
100
PubMed Central (PMC)链接
平均录用比例
较易
CITESCORE
CiteScore SJR SNIP CiteScore排名 7.20 0.986 1.078 学科 分区 排名 百分位 大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology Q1 29 / 131 78% 大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 83 / 321 74%WOS期刊JCR分区
WOS分区等级:2区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | 137/319 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q2 | 113/352 |
|
| 学科:TOXICOLOGY | SCIE | Q2 | 34/106 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | 222/320 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 221/353 |
|
| 学科:TOXICOLOGY | SCIE | Q3 | 78/106 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 医学 3区 |
| 否 | 是 |
中科院2023年12月旧的升级版
| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 医学 3区 |
| 否 | 是 |